CL Colgate Palmolive (CL) Q3 FY25 earnings call
Colgate-Palmolive navigated a challenging Q3 FY25 marked by global category slowdowns and cost inflation, delivering dollar-based EPS growth and strong cash flow. The company is accelerating its 2030 Strategy, leveraging the Strategic Growth and Productivity Program (SGPP) and significant AI investments to drive innovation, efficiency, and market share gains, particularly in emerging markets and Hill's Pet Nutrition, while proactively addressing regional challenges.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
CL operating KPIs by quarter
| KPI | This call Sep 2025 Q3 FY25 | Mar 2026 Q1 FY26 | Jun 2026 Q2 FY26 | Change vs prior quarter |
|---|---|---|---|---|
| Employees | 34KWe are seizing this moment as the 34,000 Colgate-Palmolive people around the world work to deliver on the change needed to reaccelerate growth and outperform.Source: earnings call transcript | 34KI want to make sure -- I think the 34,000 Colgate people around the world that do just extraordinary work in a very difficult environment to deliver strong results and their tireless effort needs to be recognized and thanks.Source: earnings call transcript | 34KBut more importantly, I want to thank the 34,000 Colgate people around the world who make us who we are.Source: earnings call transcript | 0% |
Operating figures the company stated on at least two of the calls shown, checked against each call's transcript. Click a figure to read the sentence. A dash means it was not stated that quarter.
Inve summary of the company's earnings call; see how call summaries are prepared. Not investment advice.